Correlation Between Pmv Pharmaceuticals and Multicell Techs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Multicell Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Multicell Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Multicell Techs, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Multicell Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Multicell Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Multicell Techs.

Diversification Opportunities for Pmv Pharmaceuticals and Multicell Techs

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pmv and Multicell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Multicell Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Multicell Techs and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Multicell Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Multicell Techs has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Multicell Techs go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Multicell Techs

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Multicell Techs. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 8.6 times less risky than Multicell Techs. The stock trades about -0.04 of its potential returns per unit of risk. The Multicell Techs is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Multicell Techs on September 4, 2024 and sell it today you would lose (0.01) from holding Multicell Techs or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Multicell Techs

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Multicell Techs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Multicell Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Multicell Techs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pmv Pharmaceuticals and Multicell Techs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Multicell Techs

The main advantage of trading using opposite Pmv Pharmaceuticals and Multicell Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Multicell Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Multicell Techs will offset losses from the drop in Multicell Techs' long position.
The idea behind Pmv Pharmaceuticals and Multicell Techs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios